Back to Results

Barry J. Maron, MD

Programs + Specialties
Training + Education Tulane University School of Medicine; Stanford University; Johns Hopkins University School of Medicine
NPI # 1871040253
Gender Male
Accepted Insurances View Accepted Insurances at Tufts MC + Tufts Children's Hospital

The Patient Rating score is an average of all responses to physician-related questions on our nationally-recognized Patient Satisfaction Survey

Tufts Medical Center
South Building, 6th Floor
800 Washington Street
Box 70
Boston, MA 02111
Phone #: 617-636-8066
Fax #: 617-636-7175

2016, NIH Great Teachers Lecture, Bethesda, MD
2014, Honoree for Clinical & Research Achievement in Hypertrophic Cardiomyopathy, Minneapolis Heart Institute Foundation Gala, Minneapolis, MN
2014, Coeur d' Or Award, Kalra Hospital, New Delhi, India and World Heart Federation, Geneva, Switzerland
2012, Simon Dack Award for Outstanding Scholarship, American College of Cardiology, Chicago, IL
2010, Edward Flanders Ricketts Award, in recognition of outstanding contribution to the field of cardiovascular medicine, Monterey, CA
2011, Israel Heart Society. Henry Neufeld Distinguished Lectureship, Tel Aviv, Israel
2010, Japanese Circulation Society. For contributions to the progress and development of hypertrophic cardiomyopathy in Japan, Kyoto, Japan
2008, American College of Cardiology, Distinguished Clinical Scientist Career Award, Chicago, IL
2008, Life achievement award for dedication and guidance in the field of cardiomyopathies. European Myocardial and Pericardial Working Group of the European Society of Cardiology, Florence, Italy
2007, Physician’s Heart and Stroke Award for outstanding research and commitment to the areas of hypertrophic cardiomyopathy and sudden death in athletes. American Heart Association, Minneapolis, MN

1. Maron BJ, Maron MS. LGE means better selection of HCM patients for primary prevention implantable defibrillators. J Am Coll Cardiol: Cardiovascular Imaging. 2016, July 14.

2. Maron BJ, Maron MS. The remarkable 50 years of imaging in hypertrophic cardiomyopathy and how it has changed diagnosis and management: from M-mode echocardiography to cardiovascular magnetic resonance. J Am Coll Cardiol Cardiovascular Imaging. 2016;9:858-872.

3. Maron BJ, Roberts WC. The father of the ventricular septal myectomy operation for obstructive hypertrophic cardiomyopathy . . . himself had familial hypertrophic cardiomyopathy: the almost unbelievable story of the Morrow family. J Am Coll Cardiol. 2016;67:2900-2903.

4. Link MS, Bockstall K, Weinstock J, Alsheikh-Ali AA, Semsarian C, Estes NAM III, Spirito P, Haas TS, Rowin EJ, Maron MS, Maron BJ. Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy: triggers, treatment and implications. Submitted.

5. Adalsteinsdottir B, Gardarsdottir M, Palsson R, Teekakirikul P, Maron MS, Appelbaum E, Maron BJ, Voldorff Madsen C, Burke, MA, Danielsen R, Desnick R, Feldt-Rasmussen U, Seidman JG, Seidman CE, Gunnarsson G. Fabry disease in families with hypertrophic cardiomyopathy. Clinical manifestations of two GLA sequence variants. Submitted.

6. Kalra A, Harris KM, Baron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ. Relation of Doppler tissue imaging parameters with heart failure progression in hypertrophic cardiomyopathy. Am J Cardiol. 2016;117:1808-1814.

7. Maron MS, Rowin EJ, Olivotti I, Casey SA, Arretini A, Tomberli B, Gerberich RF, Link MS, Chan RH, Lesser JR, Maron BJ. contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2016;67:1399-1409.

8. Maron BJ. Saving lives one at a time. JAMA Cardiol.2016;1:387-388.

9. Maron BJ, Rowin EJ, Casey SA, Maron MS. How hypertrophic cardiomyopathy became a contemporary treatable genetic disease with low mortality: shaped by 50 years of clinical research and practice. JAMA Cardiol. 2016;1:98-105.

10. Williams LK, Chan RH, Carasso S, Durand M, Misurka J, Crean AM, Ralph-Edwards A, Gruner C, Woo A, Lesser JR, Maron MS, Rakowski H. Effect of left ventricular outflow tract obstruction on left atrial mechanics in hypertrophic cardiomyopathy. Biomed Res Int. 2015;2015:481245.

Barry J. Maron, MD is the Director of Clinical Research in the Hypertrophic Cardiomyopathy Center at Tufts Medical Center. Previously, Dr. Maron was the Director of the Hypertrophic Cardiomyopathy Center program at the Minneapolis Heart Institute Foundation for 23 years. Prior to that, he was Senior Investigator in the National Institutes of Health (National Heart, Lung and Blood Institute) Cardiology Branch for 21 years.

Dr. Maron has authored 930 original peer-reviewed articles, book chapters and other contributions to the literature, as well as 325 abstracts and five books, including the well-regarded “Hypertrophic Cardiomyopathy: For Patients, Their Families and Interested Physicians.” His research initiatives have included diverse clinical and pathologic aspects of hypertrophic cardiomyopathy over a 40 year career, including development of risk stratification guidelines and introducing implantable defibrillators for effective prevention of sudden death in adults and children with hypertrophic cardiomyopathy.

American College of Cardiology
American College of Sports Medicine
American Heart Association
European Society of Cardiology
Heart Rhythm Society
The Society for Pediatric Research American Heart Association, Council on Clinical Cardiology

Graphic that says In the News

Saving patients with genetic heart disease

Duo develops strategy for preventing sudden death from HCM
Father, son Cardiovascular Specialists, Barry and Martin Maron, spread the word that HCM is now a manageable disease at Tufts Medical Center in downtown Boston, MA.

New guidelines to prevent sudden cardiac death in patients with HCM

Read about these new guidelines
Heart Icon with plus sign in the middle

World Experts in HCM Converge on Boston to Share Latest Treatments

Learn more about the HCM Summit VI
Lisa Salberg, an HCM patient at Tufts Medical Center in Boston, MA, preserved her heart for research and education after having a heart transplant.

Lisa Salberg's heart preservation experience: "Reunited with my best friend and worst enemy."

Find out more
HCM Summit VI is the three-day definitive scientific meeting on hypertrophic cardiomyopathy provided by Tufts Medical Center in downtown Boston, MA.

Hear from renowned faculty on hypertrophic cardiomyopathy at the HCM Summit VI, October 27-29 in Boston.

Learn more and register
Ethan Rowin, MD is the Co-Director of the Hypertrophic Cardiomyopathy Center at Tufts Medical Center in downtown Boston, MA.

JACC: Ethan Rowin, MD and co-authors observe clinical course and prognosis of HCM patients with LV apical aneurysms.

Read more about HCM
Father, son Cardiovascular Specialists, Barry and Martin Maron, spread the word that HCM is now a manageable disease at Tufts Medical Center in downtown Boston, MA.

The father-son duo that’s changing a cardiac narrative.

Read more about this duo
Five white stars

What do the star ratings on physician profiles mean?

Learn about the program